Understanding Medicare’s New $35 Insulin Price Cap

If you’ve ever picked up insulin and felt your wallet try to crawl out of your pocket and hide under the pharmacy counter,
you’re not alone. For years, insulin prices in the U.S. have been a roller coasterexcept you didn’t sign the waiver,
and the ride operator never asked if you’d like to keep your lunch (or your savings).

Medicare’s $35 insulin price cap is designed to bring something rare and precious to the checkout line: predictability.
No more “It was $47 last month, why is it $212 today?” energy. Instead, most people with Medicare drug coverage will pay
no more than $35 for a one-month supply of each covered insulin product.

This guide breaks down what the cap is, who it helps, what it doesn’t cover (spoiler: not everything diabetes-related),
and how to make sure you actually get the savings you’re expectingwithout needing a PhD in Medicare-ese.

Why this matters: insulin costs were a real problem

Insulin isn’t optional for many people with diabetes. It’s not a “nice-to-have,” like heated seats or fancy coffee foam art.
It’s a “keep-your-body-running” medication. When the price of something essential becomes unpredictable, people may delay
refills, stretch doses, or skip treatmentchoices that can lead to serious health complications.

The $35 cap is part of a bigger effort to lower out-of-pocket drug costs in Medicare and make medication access more stable
year to year. It won’t solve every insulin affordability issue in America, but for Medicare beneficiaries, it can be a major
financial relief.

What exactly is Medicare’s $35 insulin cap?

For Medicare Part D (prescription drug plans): the $35 limit is the headline

If you have Medicare Part D (either a stand-alone Part D plan or a Medicare Advantage plan that includes drug coverage),
you’ll generally pay no more than $35 for a one-month supply of each covered insulin product.
The cap applies across the different phases of Part D coverage (including the deductible stage), which is a fancy way of saying:
the cap isn’t supposed to disappear just because your plan’s calendar has moved into a different “phase.”

Key phrase: covered insulin product. That means the insulin is on your plan’s formulary (its list of covered drugs).
If your insulin isn’t covered, the cap can’t help until you switch to a covered option, request an exception, or change plans.

For Medicare Part B (medical insurance): the cap applies to insulin used in certain covered pumps

Some insulin is covered under Medicare Part B when it’s used with a durable medical equipment (DME)
insulin pump that Medicare covers (think traditional, non-disposable pumps billed under the DME benefit). In those cases,
your monthly coinsurance for the insulin is capped so it can’t exceed $35 for a one-month supply.

Translation: if you use insulin through a Medicare-covered DME pump, the cap can limit what you pay out of pocket for that insulin.

What the cap does not automatically cover

The insulin cap is about insulin pricingnot every diabetes supply under the sun. Depending on whether you’re using Part B or Part D,
you may still have costs for items like:

• Needles, syringes, alcohol swabs, gauze (coverage varies by Part B vs Part D rules)
• Insulin pump supplies (tubing, cartridges, infusion sets), which often follow different cost-sharing rules
• Continuous glucose monitors (CGMs) and test strips (covered differently, with separate rules)
• Disposable “patch” pumps may not be capped at $35 as a deviceeven when the insulin that goes into them is capped

The fine print that actually affects real people

1) “Per insulin product” can mean more than one $35 cap

Many people use more than one type of insulinlike a long-acting (basal) insulin plus a rapid-acting (mealtime) insulin.
The cap is typically described as $35 per month’s supply of each insulin product.

So if you take two covered insulins, you could pay up to $70/month for insulin (still often far less than before),
plus whatever you pay for other medications and supplies.

2) Three-month refills usually scale up (but stay predictable)

If you get a 90-day supply, you generally shouldn’t pay more than $35 per month for each covered insulin product
which often works out to about $105 for a three-month supply of that insulin.

3) Preferred vs. non-preferred pharmacies: the cap still applies, but networks still matter

Many Part D plans have “preferred” pharmacies that give you better pricing on lots of meds. The $35 insulin cap should apply
whether you use a preferred or non-preferred pharmacy, but your other medications may cost more outside preferred networks.
Also, some plans are strict about mail-order rules or where you can fill certain prescriptions.

4) Extra Help (Low-Income Subsidy): you may already pay less than $35

If you qualify for Extra Help, your insulin costs may already be lower than $35. In that case, the cap is like a speed limit you
were already driving under. The cap doesn’t force you up to $35it just prevents higher charges for covered insulin.

5) Patch pumps: insulin may be capped, but the pump device may not be

Here’s a common “wait, what?” moment: some disposable patch pumps and related supplies are treated differently than insulin itself.
Your insulin might be capped at $35 if it’s covered, but the patch pump device (as a supply) may have
separate cost-sharing rules and could cost more than $35especially if your plan applies a deductible to supplies.

How to make sure you actually get the $35 cap

The cap is powerful, but it’s not a magical coupon that automatically scans itself. To make sure you benefit:

1. Confirm how your insulin is covered.
   Is it under Part D (pharmacy benefit) or Part B (DME pump insulin)? The rules differ.
2. Check your plan’s formulary.
   Make sure your exact insulin (brand, formulation, and delivery type) is covered.
3. Ask the pharmacy to run it correctly.
   Billing glitches happen. If the price looks wrong, ask them to reprocess and confirm it’s billed through your Part D plan.
4. If you use a pump, verify the pump category.
   Traditional DME pumps can place insulin under Part B rules; patch pumps often place insulin under Part D.
5. Review your plan during Open Enrollment.
   Medicare plans can change formularies and pharmacy networks each year. What worked last year might get weird this year.

What kind of savings are we talking about? (Realistic examples)

Savings depend on what you used to pay. Some people already had reasonable copays. Others were paying eye-watering prices.
Here are a few simple examples to show how the math can work:

Example A: One insulin, previously high copay

Maria uses one covered long-acting insulin and used to pay $120 per month out of pocket. With the cap:

• Old cost: $120/month
• New cost: $35/month
• Estimated savings: $85/month (about $1,020/year)

Example B: Two insulins (basal + mealtime)

David uses two covered insulin products and used to pay $90 for one and $65 for the other each month:

• Old total: $155/month
• New total (cap applies to each product): $35 + $35 = $70/month
• Estimated savings: $85/month (about $1,020/year)

Example C: Three-month refill

Anita prefers 90-day refills for convenience. If her insulin is covered, a 3-month supply should generally cost no more than
about $105 per insulin product (3 × $35). That’s still a big deal if the prior 90-day cost was several hundred dollars.

Important: these examples assume the insulin is covered and processed correctly. If the insulin isn’t on formulary, the cap won’t show up
until the coverage issue is fixed.

How the $35 insulin cap fits into bigger Medicare drug changes (especially in 2026)

Think of the insulin cap as one tool in a growing toolkit for lowering out-of-pocket costs in Medicare. In 2026, Medicare also includes
broader changes to prescription drug spendinglike an annual out-of-pocket cap for Part D covered drugs and a payment option that can help
people spread costs over the year.

The annual Part D out-of-pocket cap

Starting in 2026, Medicare Part D includes an annual out-of-pocket maximum (a hard ceiling for what you pay for covered Part D drugs that year).
That doesn’t replace the $35 insulin capit’s a bigger umbrella. The insulin cap helps month-to-month; the annual cap helps year-to-year.

The Medicare Prescription Payment Plan

Medicare also offers an option that lets people spread out out-of-pocket prescription drug costs into monthly payments rather than paying
large amounts at the pharmacy early in the year. This doesn’t necessarily reduce total costs by itself, but it can make budgeting less painful.
(Think “monthly payment plan,” not “discount.”)

Common misunderstandings (a quick myth-busting pit stop)

• Myth: “All insulin is $35 for everyone.”
  
  Reality: The cap applies in Medicare (Part D, and certain Part B pump situations) and only to insulin products covered by the plan.
• Myth: “My insulin should be $35 even if it’s not on my plan.”
  
  Reality: Formularies matter. If it’s not covered, you may need an exception or a different plan/insulin option.
• Myth: “Everything diabetes-related is capped at $35.”
  
  Reality: Insulin is capped; many supplies and devices follow separate rules.
• Myth: “If the pharmacy price is wrong, I’m stuck.”
  
  Reality: Billing errors happen. Ask the pharmacy to re-run it and call your plan if needed.

FAQ: quick answers to questions people actually ask

Does the $35 insulin cap apply during the deductible phase?

For covered insulin under Part D, the cap is designed to apply even in phases where you’d normally pay morelike the deductible stage.
If you’re seeing a higher charge for covered insulin, it’s worth asking your plan or pharmacy why.

What if I use insulin with a pump?

It depends on the pump type and how it’s covered. Traditional DME pumps can place insulin under Part B rules; some other pump setups
may use Part D. The insulin cap can apply in either pathway, but the details differand pump supplies may have separate costs.

Can my insulin cost less than $35?

Yes. $35 is the maximum for a one-month supply of a covered insulin product. Some plans may charge less.

Do I need to “apply” for the cap?

Generally, no. If you’re enrolled in a Part D plan and your insulin is covered, the cap should show up automatically when billed correctly.

Bottom line: this cap is a winbut you still have to play it smart

Medicare’s $35 insulin price cap is one of the most practical drug-cost changes in years: it takes a life-sustaining medication and makes
the price far more predictable. For many people, that predictability is almost as valuable as the savings.

Still, the cap works best when your insulin is on your plan’s formulary, your pharmacy billing is correct, and you understand whether your
insulin is being covered under Part D or Part B. In other words: Medicare made the rule simpler, but real life still has fine print.

If you’re unsure about your situation, start with your pharmacist (they see billing patterns all
:
day), then call your plan for confirmation.
And if you want a neutral helper who speaks “human,” your local State Health Insurance Assistance Program (SHIP) can help people compare plans
and understand coverage options.

Experiences related to the $35 insulin cap (real-life-style scenarios)

The stories below are compositesbuilt from the kinds of situations Medicare beneficiaries commonly faceso you can see how the $35 cap plays out
in everyday life. Think of them as “this could be you (or your uncle, neighbor, or the world’s most organized grandma)” examples.

1) The “Fixed Income, Flexible Prices” problem finally gets less flexible

Janet lives on Social Security and a small pension. Before the cap, her insulin cost would “mysteriously” change depending on the time of year and
which coverage phase her Part D plan thought she was in. One month she’d pay something manageable. The next month she’d stare at the register like it
personally betrayed her. The cap doesn’t make insulin free, but it makes it predictable. That matters when you budget down to the last few dollars,
because “surprise” is fun at birthday parties and terrible at pharmacies.

2) Two insulins, two caps, one calmer caregiver

Marcus helps manage his dad’s medications. His dad uses both a long-acting insulin and a mealtime insulin. Marcus assumed “$35 insulin” meant
everything would be $35 total. Then he learned it’s $35 per covered insulin product per monthso closer to $70 for two insulins. Still, compared to
what they used to pay, it was a relief. The bigger benefit? Planning. Marcus can now estimate monthly costs without keeping an emergency “pharmacy
surprise fund” on standby.

3) The “Why is my patch pump not $35?” moment

Denise uses a patch pump and loves it because it fits her life. But at the start of the year, she noticed something confusing: her insulin looked capped,
but the patch pump supplies didn’t. After a few calls (and one very patient pharmacist), she learned that insulin and supplies can be treated differently.
Her lesson: when you’re comparing Part D plans, don’t just check “Does it cover my insulin?” Also check “How does it cover my device and supplies?”
The cap helps a lot, but it’s not a blanket discount on every item in the diabetes aisle.

4) The snowbird strategy: stable insulin pricing across locations

Robert spends summers up north and winters down south. His biggest headache wasn’t just the price of insulinit was getting it smoothly while traveling.
With the cap in place, the cost is less likely to swing wildly when he fills in a different state or uses mail order (assuming the insulin is covered and
billed correctly). His practical tip: he keeps a short “coverage checklist” on his phoneplan name, member ID, preferred pharmacies, and the exact insulin
name and strengthso if anything prices out wrong, he can troubleshoot faster.

5) Budgeting in 2026: pairing the insulin cap with the payment plan option

Sonia’s experience is more about cash flow than total cost. She takes insulin plus a few other medications. The insulin cap keeps her insulin portion
predictable, but the other meds used to hit hard early in the year. In 2026, she looks at the option to spread out out-of-pocket drug costs into monthly
payments (instead of paying larger amounts at the pharmacy early on). Her takeaway: the insulin cap is a “price guardrail,” while the payment plan option
can be a “budgeting tool.” Together, they can make monthly expenses feel less like a financial jump scare.

The common thread in all these experiences is simple: the $35 cap is most valuable when it reduces uncertainty. It can also expose a helpful reality:
if something doesn’t look rightif you’re charged more than expectedthere’s usually a specific reason (coverage, billing, formulary status, supply vs drug).
That means there’s also usually a specific fix.